BAINCO INTERNATIONAL INVESTORS - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.7%.

Quarter-by-quarter ownership
BAINCO INTERNATIONAL INVESTORS ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$3,858,000
-6.6%
152,839
+39.5%
0.44%
-15.8%
Q3 2020$4,132,000
+30.8%
109,550
+48.5%
0.52%
+17.2%
Q2 2020$3,160,000
+114.2%
73,794
-2.7%
0.45%
+73.6%
Q1 2020$1,475,000
-26.0%
75,850
-1.0%
0.26%
-9.2%
Q4 2019$1,992,000
-79.5%
76,650
-78.5%
0.28%
-81.1%
Q3 2019$9,700,000
+1.5%
355,9130.0%1.50%
-0.5%
Q2 2019$9,556,000
-6.5%
355,913
+0.7%
1.51%
-9.3%
Q1 2019$10,217,000353,4131.66%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$45,386,0009.32%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$472,400,0005.23%
Wildcat Capital Management, LLC 1,515,524$38,252,0004.81%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 900,143$22,720,0003.28%
Coastal Bridge Advisors, LLC 385,824$9,738,0001.93%
Casdin Capital, LLC 945,000$23,852,0000.71%
DSAM Partners (London) Ltd 208,798$5,270,0000.62%
BAINCO INTERNATIONAL INVESTORS 152,839$3,858,0000.44%
Pier Capital, LLC 152,071$3,838,0000.41%
Woodline Partners LP 567,539$14,325,0000.38%
View complete list of ALLOGENE THERAPEUTICS INC shareholders